Geulah Livshits

Stock Analyst at Chardan Capital

(4.57)
# 287
Out of 5,031 analysts
225
Total ratings
52%
Success rate
29.29%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Geulah Livshits

Taysha Gene Therapies
Oct 17, 2025
Maintains: Buy
Price Target: $12
Current: $4.72
Upside: +154.24%
Rocket Pharmaceuticals
Oct 14, 2025
Maintains: Buy
Price Target: $11
Current: $3.71
Upside: +196.50%
Lexeo Therapeutics
Oct 7, 2025
Maintains: Buy
Price Target: $15$17
Current: $9.58
Upside: +77.45%
Palvella Therapeutics
Sep 26, 2025
Maintains: Buy
Price Target: $60$73
Current: $73.15
Upside: -0.21%
Immuneering
Sep 26, 2025
Maintains: Buy
Price Target: $13$20
Current: $5.58
Upside: +258.42%
Krystal Biotech
Aug 22, 2025
Maintains: Buy
Price Target: $219$216
Current: $190.23
Upside: +13.55%
Metagenomi
Aug 15, 2025
Maintains: Buy
Price Target: $12$11
Current: $3.05
Upside: +260.66%
Solid Biosciences
Aug 14, 2025
Maintains: Buy
Price Target: $15
Current: $5.88
Upside: +155.10%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $25
Current: $9.84
Upside: +154.07%
Intellia Therapeutics
Aug 11, 2025
Maintains: Buy
Price Target: $68$60
Current: $24.75
Upside: +142.42%
Maintains: Buy
Price Target: $12$10
Current: $5.45
Upside: +83.49%
Maintains: Buy
Price Target: $12
Current: $2.15
Upside: +458.14%
Maintains: Buy
Price Target: $25$20
Current: $2.18
Upside: +817.43%
Maintains: Buy
Price Target: $9
Current: $1.81
Upside: +397.24%
Maintains: Buy
Price Target: $82
Current: $69.15
Upside: +18.58%
Maintains: Buy
Price Target: $120
Current: $8.07
Upside: +1,386.99%
Maintains: Buy
Price Target: $7$6
Current: $0.54
Upside: +1,006.40%
Downgrades: Neutral
Price Target: n/a
Current: $3.77
Upside: -
Reiterates: Buy
Price Target: $41
Current: $7.75
Upside: +429.03%
Maintains: Buy
Price Target: $28$25
Current: $9.87
Upside: +153.29%
Reiterates: Buy
Price Target: $12
Current: $2.85
Upside: +321.05%
Maintains: Neutral
Price Target: $191$208
Current: $26.01
Upside: +699.69%
Maintains: Buy
Price Target: $15$16
Current: $0.93
Upside: +1,627.30%
Maintains: Buy
Price Target: $100$90
Current: $11.73
Upside: +667.26%
Maintains: Neutral
Price Target: $5.5$4
Current: $4.95
Upside: -19.19%
Maintains: Neutral
Price Target: $50$30
Current: $4.29
Upside: +599.30%
Initiates: Buy
Price Target: $18
Current: $15.67
Upside: +14.87%